Opendata, web and dolomites

GDS

A safe and effective non-surgical and reversible procedure for weight loss

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "GDS" data sheet

The following table provides information about the project.

Coordinator
ALLEVETIX MEDICAL LTD 

Organization address
address: 2 HAESHEL STREET, CAESAREA INDUSTRIAL PARK
city: CESAREA
postcode: 3088900
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://allevetix-medical.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ALLEVETIX MEDICAL LTD IL (CESAREA) coordinator 50˙000.00

Map

 Project objective

With nearly 15% of the current population over 18 years old obese, obesity is on the verge of becoming a global pandemic. Obesity can lead to serious health issues, like diabetes, coronary heart diseases and several types of cancers. Each year obesity related conditions cost globally over €1.7 trillion and cause almost 2.8 million deaths a year. It is estimated that the EU spends almost 7% of their GDP in obesity treatments. Current gold standard for weight loss is effective, but extremely expensive and has life-threating side-effects. The GDS is an innovative non-surgical procedure for weight loss, that is reversible, it is 7 times cheaper than the golden standard (RYGB) and almost 4 times cheaper than alternative procedures, and can be done in 30 minutes without hospitalization time or the need of big surgical team. The GDS is composed of a polymeric flexible sleeve inserted in the duodenum with a patented anchoring system to stop the sleeve from migrating to the small intestine. The sleeve prevents weight gain through malabsorption of calories and the anchor increases the satiety sensation in the user. Allevetix has already performed successful pre-clinical trials on animals. Within the overall innovation project Allevetix requires to miniaturize the GDS; conduct a First in Human safety clinical trial, and safety and efficacy Pivotal Clinical trial; setup a production line with an external CMO; obtain the CE mark; and prepare a sound commercialization and got-to-market strategy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GDS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GDS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

Presque (2019)

Smart Nursing Bra

Read More  

EDITUS (2019)

Helping our customers to design smart and safe tomorrows’ communication systems

Read More